Berikutnya

Putar otomatis

Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways

0 Tampilan • 07/04/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Earn CME for related activities: https://www.naccme.com/oln

This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.

© 2018 NACCME, an HMP Company

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis